[go: up one dir, main page]

WO2015152724A3 - Biomarkers for the detection of frontotemporal dementia - Google Patents

Biomarkers for the detection of frontotemporal dementia Download PDF

Info

Publication number
WO2015152724A3
WO2015152724A3 PCT/NL2015/050216 NL2015050216W WO2015152724A3 WO 2015152724 A3 WO2015152724 A3 WO 2015152724A3 NL 2015050216 W NL2015050216 W NL 2015050216W WO 2015152724 A3 WO2015152724 A3 WO 2015152724A3
Authority
WO
WIPO (PCT)
Prior art keywords
frontotemporal dementia
biomarkers
detection
ftd
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/NL2015/050216
Other languages
French (fr)
Other versions
WO2015152724A2 (en
Inventor
Johannes Cornelis VAN SWIETEN
Yolande Anna Lucia PIJNENBURG
Charlotte Elisabeth Teunissen
Cornelia Ramona Jimenez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vrije Universiteit Amsterdam
Original Assignee
Stichting VU VUMC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting VU VUMC filed Critical Stichting VU VUMC
Publication of WO2015152724A2 publication Critical patent/WO2015152724A2/en
Publication of WO2015152724A3 publication Critical patent/WO2015152724A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The present invention relates to methods and kits for classifying an individual as being afflicted with frontotemporal dementia (FTD). The invention further relates to the discrimination between different subtypes of FTD.
PCT/NL2015/050216 2014-04-02 2015-04-02 Biomarkers for the detection of frontotemporal dementia Ceased WO2015152724A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14163237 2014-04-02
EP14163237.2 2014-04-02

Publications (2)

Publication Number Publication Date
WO2015152724A2 WO2015152724A2 (en) 2015-10-08
WO2015152724A3 true WO2015152724A3 (en) 2015-11-26

Family

ID=50397033

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2015/050216 Ceased WO2015152724A2 (en) 2014-04-02 2015-04-02 Biomarkers for the detection of frontotemporal dementia

Country Status (1)

Country Link
WO (1) WO2015152724A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3376230A1 (en) 2017-03-13 2018-09-19 Biocross, S.L. Identification of signatures for neurodegeneration diseases diagnoses
EP3655531B1 (en) * 2017-07-18 2024-09-04 Exosome Diagnostics, Inc. Sequencing of nucleic acids associated with exosomal isolation from patients with glioblastoma multiforme
WO2023278598A1 (en) * 2021-06-30 2023-01-05 Mitsubishi Tanabe Pharma Corporation Als treatment method, als pharmaceutical composition, and als diagnostic method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050106586A1 (en) * 2003-06-13 2005-05-19 Mount Sinai Hospital Detection of neurodegenerative diseases
WO2011061304A1 (en) * 2009-11-20 2011-05-26 Pharnext New diagnostic tools for charcot-marie-tooth disease
US20110143380A1 (en) * 2006-03-14 2011-06-16 The Washington University Alzheimer's disease biomarkers and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8804074D0 (en) 1988-11-10 1988-11-10 Pharmacia Ab SENSOR UNIT AND ITS USE IN BIOSENSOR SYSTEM
ATE242485T1 (en) 1993-05-28 2003-06-15 Baylor College Medicine METHOD AND MASS SPECTROMETER FOR THE DESORPTION AND IONIZATION OF ANALYTES
US5463564A (en) 1994-09-16 1995-10-31 3-Dimensional Pharmaceuticals, Inc. System and method of automatically generating chemical compounds with desired properties
JP4006523B2 (en) 2003-04-10 2007-11-14 独立行政法人産業技術総合研究所 Protein array and production method thereof
US7794948B2 (en) 2003-11-07 2010-09-14 Vermilllion, Inc. Biomarkers for alzheimer's disease
EP2588144B1 (en) 2010-07-02 2018-05-09 Ventana Medical Systems, Inc. Detecting targets using mass tags and mass spectrometry

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050106586A1 (en) * 2003-06-13 2005-05-19 Mount Sinai Hospital Detection of neurodegenerative diseases
US20110143380A1 (en) * 2006-03-14 2011-06-16 The Washington University Alzheimer's disease biomarkers and methods of use
WO2011061304A1 (en) * 2009-11-20 2011-05-26 Pharnext New diagnostic tools for charcot-marie-tooth disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
H. SEELAAR ET AL: "Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review", JOURNAL OF NEUROLOGY, NEUROSURGERY & PSYCHIATRY, vol. 82, no. 5, 22 October 2010 (2010-10-22), pages 476 - 486, XP055132232, ISSN: 0022-3050, DOI: 10.1136/jnnp.2010.212225 *

Also Published As

Publication number Publication date
WO2015152724A2 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
WO2015165779A3 (en) Small ncrnas as biomarkers
WO2015114506A3 (en) Biosensors for the detection of infection and associated maladies
WO2016077381A8 (en) Anti-interleukin-33 antibodies and uses thereof
EP3195562A4 (en) Detection and repair of broken single sign-on integration
WO2016196765A3 (en) Companion methods and kits for il-2-based therapies and mesenchymal stem cell-based therapies
EP3510173A4 (en) Methods and systems for detecting usual interstitial pneumonia
WO2016061389A3 (en) Anti-alpha-synuclein antibodies and methods of use
WO2015187018A3 (en) Means and methods for determining t cell recognition
EP3215836A4 (en) Devices, systems, and methods for the detection of analytes
SI3455625T1 (en) Methods for predicting the usefulness of neoantigens for immunotherapy
EP3308158A4 (en) Adipocyte-derived exosomes, and compositions, kits, and methods of using the same for detection and screening
EP3546947A3 (en) Biomarker panels for brain injury complications
EP3134552A4 (en) Methods, processes, devices and kits for the measurement of post traumatic stress disorder microrna markers
EP3149212A4 (en) Electrochemical methods and compounds for the detection of enzymes
EP3204771A4 (en) Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease
EP3129036A4 (en) Yeast-based immunotherapy and type i interferon sensitivity
EP3292395A4 (en) Methods and systems for the detection of analytes
EP3213062A4 (en) Methods and assays relating to sepiapterin reductase inhibition
WO2015152724A3 (en) Biomarkers for the detection of frontotemporal dementia
WO2015181779A3 (en) Dna methylation status as a biomarker of alcohol use and abstinence
EP3102695A4 (en) Process, apparatus or system and kit for classification of tumor samples of unknown and/or uncertain origin and use of genes of the group of biomarkers
HK1231512A1 (en) Methods for detecting multiple nucleic acids in a sample
EP3380515A4 (en) Kits for detection of hepcidin
WO2015170187A3 (en) Improved enrichment methods
PT3673075T (en) Method for the specific detection of microorganisms

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15721891

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15721891

Country of ref document: EP

Kind code of ref document: A2